Future Directions in Maintenance Therapy in Multiple Myeloma

Autologous stem cell transplantation (ASCT) has been a backbone of therapy for newly diagnosed patients with multiple myeloma eligible for high-dose therapy for decades. Survival outcomes have continued to improve over time, in part because of the incorporation of highly effective induction regimens...

Descripción completa

Detalles Bibliográficos
Autores principales: Holstein, Sarah A., Suman, Vera J., Hillengass, Jens, McCarthy, Philip L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197068/
https://www.ncbi.nlm.nih.gov/pubmed/34073689
http://dx.doi.org/10.3390/jcm10112261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197068/
https://www.ncbi.nlm.nih.gov/pubmed/34073689
http://dx.doi.org/10.3390/jcm10112261

Ejemplares similares